Drugs with actions on haemostasis should be given with caution to patients on antifibrinolytic therapy. The potential for thrombus formation may be increased by estrogens, for example, or the action of the antifibrinolytic antagonized by compounds such as thrombolytics.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign Out
